C3TI’s areas of interest span drug development programs, therapeutic areas, and disciplines. Learn more.
Similar Posts
FDA grants accelerated approval to sunvozertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations
On July 2, 2025, the Food and Drug Administration granted accelerated approval to sunvozertinib (Zegfrovy, Dizal (Jiangsu) Pharmaceutical Co., Ltd.) for adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertioFDA alerts drug manufacturers to the risk of benzene contamination in certain drugs
FDA is evaluating the root cause of benzene contamination in certain drugs and alerting drug manufacturers to the risk of benzene contamination from drug components and other potential risk factorsSouth Asian Food Inc. Issues Allergy Alert on Undeclared Peanuts in “Bengal King Jhal Chanachur “
South Asian Food Inc. of Maspeth, Queens, NY, is recalling its 12.34oz (350gm) packages of Bengal King Jhal Chanachur food treats because they may contain undeclared peanuts. People who have allergies to peanuts run the risk of serious or life-threatening allergic reaction if they consume these prodQ&A on CGMP Requirements
Pharmaceutical Quality/Manufacturing Standards (CGMP)Spring & Mulberry Expands Voluntary Recall of Select Chocolate Bars Due to Possible Salmonella Contamination
Raleigh, North Carolina (January 14, 2026) — Spring & Mulberry is updating their press release previously issued on January 12, 2026, to expand their voluntary recall beyond Mint Leaf to include additional flavors (see table below), due to possible contamination with Salmonella.Sprout Organics Expands Voluntary Recall of Sweet Potato Apple and Spinach to Include Additional Lot Codes
Sprout Organics is expanding its September 16, 2025 recall of Sprout Organics® Sweet Potato Apple and Spinach, due to potentially elevated lead levels, to include additional lots.